Hematologist
CION Cancer Clinics
Risk groups in childhood ALL, explained for parents | CION Cancer Clinics
Childhood ALL is sorted into risk groups so each child gets enough treatment, and no more than they need. The team looks at age, white cell count, B-cell or T-cell type, genetic changes in the leukaemia cells and, above all, how quickly the leukaemia clears. The first group can change after the first month. This page explains what the labels mean and what they cannot tell you. At CION Cancer Clinics, our haematology team supports patients and families through treatment, cost questions and life at home.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What is a risk group in childhood ALL?
- Which findings decide the risk group?
- When is the risk group decided, and can it change?
- What do the words on the report mean?
- What actually changes if my child is in a higher risk group?
- What do families often believe about risk groups?
- What can this page not tell you about your child?
- Common questions about risk groups in childhood ALL
The short answer
What is a risk group in childhood ALL?
A risk group is the label the team gives your child's leukaemia to decide how strong the treatment needs to be. It is not a verdict on your child. It is a way of giving enough treatment to control the leukaemia without giving more than your child needs.
Why children with the same illness get different plans
ALL, or acute lymphoblastic leukaemia, is not one single disease. Some leukaemias respond quickly to fairly gentle treatment. Others need stronger medicines for longer.
Names differ between protocols
A protocol is the written treatment plan a hospital follows. Different protocols use different words for the same idea. You may see standard risk, low risk, intermediate risk, high risk or very high risk. Do not compare labels with other children. Ask your team which protocol they use and what your child's group means inside it.
The first risk group is often provisional. It can change once the team sees how the leukaemia responds to the first month of treatment.What the team looks at
Which findings decide the risk group?
No single result decides it. Response to treatment usually carries the most weight.
Age and white cell count at diagnosis
Many protocols start here. A child aged at least one and younger than ten, with a white cell count below 50,000 per microlitre at diagnosis, is often placed in a standard group to begin with.
Laboratory reference ranges differ, and one count is always read with the rest of the picture.B-cell or T-cell type
ALL starts in either B cells or T cells, two kinds of immune cell. T-cell ALL is usually treated a little more strongly from the start, though many children with it do well.
Changes inside the leukaemia cells
Laboratory tests look at the chromosomes and genes of the leukaemia cells. Some changes point to a leukaemia that responds well. Others point to one that needs more.
Tests you may hear about
- Cytogenetics or karyotype
- FISH
- PCR for specific gene changes
How fast the leukaemia clears
This is often the strongest guide of all. Blood and bone marrow are checked during and at the end of the first phase to see how much leukaemia is left. A very low level is a good sign.
The brain and spinal fluid
A lumbar puncture checks the fluid around the brain and spine for leukaemia cells. If cells are found there, extra treatment to that area is added to the plan.
Not sure whether this applies to you?
Ask an oncologistThe timing
When is the risk group decided, and can it change?
-
At diagnosis: a first group
Based on age, white cell count and B-cell or T-cell type. Treatment starts straight away without waiting for every result.
-
The first few weeks: genetic results arrive
Tests on the leukaemia cells take longer. When they come back, the team may move your child to a different group. This is normal and expected.
-
During induction: early response
Induction is the first phase of treatment. Some protocols check the blood or marrow part way through to see how quickly the leukaemia is falling.
-
End of induction: the key marrow test
A bone marrow test measures MRD, the tiny amount of leukaemia left that a microscope alone cannot see. This result often confirms or changes the group.
-
Later checks in some protocols
If MRD is still present, it may be measured again after the next phase. The plan is adjusted to that result. Moving up is not a failure.
On your report
What do the words on the report mean?
- Standard or low risk
- The leukaemia has features that usually respond well. Treatment is still serious and still long, but lighter in some phases.
- Intermediate risk
- Somewhere in between. Some extra treatment is added to the standard plan.
- High or very high risk
- Features that call for stronger treatment. For a small number of children, a stem cell transplant is discussed.
- MRD
- Minimal residual disease. The very small number of leukaemia cells left after treatment, measured with sensitive laboratory tests.
- Hyperdiploid or ETV6-RUNX1
- Changes in the leukaemia cells that usually point to a good response.
- Philadelphia chromosome, KMT2A, iAMP21
- Changes that usually lead to a stronger plan. Philadelphia-positive ALL also gets a targeted tablet added.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
In practice
What actually changes if my child is in a higher risk group?
The main change is how much treatment your child gets, not whether they get treated. A higher group usually means more medicines in the middle phases, more hospital days and closer checks. The overall shape stays the same: induction, then consolidation, then a long maintenance phase at home.
Stronger phases, more visits
Children in higher groups often have a longer intensive stretch in the middle of treatment. The whole course, from diagnosis to the last tablet, usually runs for about two to three years in every group.
Targeted medicines and transplant
Philadelphia-positive ALL has a targeted tablet added to chemotherapy. A stem cell transplant is considered only for a small group of children whose leukaemia does not clear well or carries very high-risk features. Most children with ALL never need one. CION does not carry out transplants. The haematology team reviews the case, presents it at a tumour board and helps you reach a qualified transplant centre if it is advised.
Who a lighter plan does not suit
If the leukaemia has high-risk features, a lighter plan raises the chance of it coming back. Share your worries, but let the team set the intensity.
Commonly believed
What do families often believe about risk groups?
"High risk means our child will not survive."
High risk means the leukaemia needs stronger treatment. It does not tell you how your child's story ends. Ask your haematologist what the group means for your child, not for children in general.
"Standard risk means it is a mild leukaemia, so we can
relax."
Standard risk ALL is still a serious illness with a long treatment. Missed tablets, late clinic visits and skipped blood tests can all let the leukaemia back in. The label lowers the intensity, not the importance.
"If the group moved up, the treatment has
failed."
A change of group after the end-of-induction marrow test is part of how protocols are built. The first label is a starting estimate. Adjusting it is the system working as designed.
"Another child had the same leukaemia and a shorter
plan, so ours must be wrong."
Children with the same diagnosis can have different genetic changes, responses and protocols. If unsure, ask for the reasons or seek a second opinion.
Being straight with you
What can this page not tell you about your child?
This page cannot tell you your child's risk group or outlook. That comes from the full set of results, the protocol your team follows and how your child responds over the coming months.
Questions worth asking the team
Which protocol are you following? Which group is my child in right now, and is it final? Which results are still pending? What was the MRD result at the end of induction? What would move my child to a different group? Write the answers down.
Getting a second look
If you have results from another hospital, bring every report, including the flow cytometry and genetic results. The CION haematology team can go through them with you. A second look does not mean starting again.
Questions we are asked
Common questions about risk groups in childhood ALL
How many risk groups are there?
It depends on the protocol. Some use two groups, some three, some four. The names differ too. What matters is where your child sits in your own team's plan. Ask them to explain the group in plain words and what it changes in the treatment.
Why was my child's group changed after a month?
The end of the first phase is when the team gets the MRD result and usually the genetic results too. These are more informative than the findings at diagnosis. A change at this point is common and planned for. It means the treatment is being matched to how your child's leukaemia actually behaves.
Can the group move down as well as up?
In some protocols, yes. A child who started in a higher group because of a high white cell count may move to a lower one if the genetic results are favourable and the leukaemia clears quickly. Other protocols keep children in the higher group once placed there. Your team will tell you which rule applies.
Does a higher risk group mean a transplant?
Usually not. Most children in higher groups are treated with stronger chemotherapy alone. A transplant is reserved for a small number with very high-risk features or leukaemia that does not clear well. If it is suggested, ask why, what the alternatives are, and which centre would carry it out.
Is T-cell ALL always high risk?
Not always. T-cell ALL is often treated more strongly from the start, and some protocols place it in a higher group straight away. But the response to treatment still matters a great deal, and the MRD result shapes the plan as much as the cell type.
What is MRD and why does it matter so much?
MRD is the tiny amount of leukaemia left after treatment, too small to see under an ordinary microscope. Sensitive tests such as flow cytometry or PCR can measure it. A child whose MRD falls very low early is responding well. A child whose MRD stays higher usually needs more treatment.
Should we ask for a lighter plan to reduce side effects?
Tell the team exactly what worries you, whether it is infections, school, fertility or money. They can often support your child through the hard phases. But the intensity of treatment is set to the leukaemia's risk. Reducing it on your own raises the chance of the leukaemia coming back.
Does a risk group decide the cost of treatment?
It can affect it, because higher groups often mean more hospital stays and more medicines. Aarogyasri, PM-JAY, CGHS, ECHS, EHS and cashless insurance may cover much of it. Check the current rules. Ask the team for an estimate against your child's own plan.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Childhood Acute Lymphoblastic Leukemia Treatment (PDQ) - Patient Version
- American Cancer Society — Leukemia in Children
- Leukemia & Lymphoma Society — Acute Lymphoblastic Leukemia (ALL)
- NHS — Acute lymphoblastic leukaemia
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
MRD in Childhood LeukaemiaThe result that most often confirms or changes the groupALL Treatment Phases in ChildrenHow induction, consolidation and maintenance fit togetherThe Long Maintenance Phase: Two Years at HomeWhat the longest part of treatment looks like at homePaediatric Blood CancersEvery guide for parents of a child with a blood cancer
Talk to us
Have your child's reports and a risk group you do not understand?
Bring or send every report. The CION haematology team will go through the results with you and explain what the group means. One helpline serves every CION centre.